Bulletin from the Extraordinary General Meeting in Oncopeptides AB (publ)
Stockholm, Sweden – 17 December 2019 – An Extraordinary General Meeting in Oncopeptides AB (publ) (ONCO) was held today, at Tändstickspalatset in Stockholm. At the Extraordinary General Meeting, the following principal resolutions were passed.· It was resolved, in accordance with the Board of Directors’ proposal, to issue not more than 2,200,000 warrants in order to ensure delivery of shares under the incentive program Co-worker LTIP 2019, adopted by the Annual General Meeting 2019. · It was resolved, in accordance with the Nomination Committee’s proposal, to issue not more than 23,491